Stanford University
Showing 3,301-3,350 of 13,032 Results
-
Adina S. Fischer, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Nico Fischer
Affiliate, Psych/Public Mental Health & Population Sciences
Bio2022-2026 Santa Clara High School
Advisor, Stanford Center for Youth Mental Health and Wellbeing
Chair, County of Santa Clara Youth Task Force -
Stephen Fischer
Associate Professor of Anesthesia at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsPreoperative evaluation of the medically complex, patient; cost-effectiveness of preop diagnostic testing; patient, outcome studies in relation to preoperative preparation; computer, database of patient perioperative data; development of the, Anesthesia Preoperative Clinic as a model of quality, efficient, and, cost-effective care.
-
Kevin Fish
Professor of Anesthesia at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsNeurological dysfunction after cardiopulmonary bypass;, metabolism of inhalation anesthetics.
-
Ann Caroline Fisher, MD
Clinical Professor, Ophthalmology
BioCaroline Fisher, MD, is a Clinical Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.
She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.
Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Engagement Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Development and Engagement for the Department of Ophthalmology. -
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine, Emeritus
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Philip Andrew Fisher
Diana Chen Professor of Early Childhood Learning and Professor, by courtesy, of Pediatrics
BioDr. Philip Fisher is the Diana Chen Professor of Early Childhood Learning in the Graduate School of Education and the Director of the Stanford Center on Early Childhood. His research, focuses on developing and evaluating scalable early childhood interventions in communities, and on translating scientific knowledge regarding healthy development under conditions of adversity for use in social policy and programs. He is particularly interested in the effects of early stressful experiences on children's development, and in prevention and treatment programs for improving children's functioning in areas such as relationships with caregivers and peers, social-emotional development, and academic achievement. He is currently the lead investigator in the ongoing RAPID-EC project, a national survey on the well-being of households with young children during the COVID-19 pandemic. Dr. Fisher is the developer of a number of widely implemented evidence-based interventions for supporting healthy child development in the context of social and economic adversity, including Treatment Foster Care Oregon for Preschoolers (TFCO-P) and Kids in Transition to School (KITS). Most recently, he developed the Filming Interactions to Nurture Development (FIND) video coaching program for supporting parenting in the home environment and early childhood care and education professionals in childcare and preschool contexts. He has published over 250 scientific papers in peer reviewed journals. He is the recipient of the 2012 Society for Prevention Research Translational Science Award, and a 2019 Fellow of the American Psychological Society.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Daniel Owen Fishman
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Blood & Marrow TransplantationBioAfter graduating from Vanderbilt Medical School, Dr. Fishman completed the Psychiatry Residency Program at University of Pittsburgh Medical Center, where he served as Chief Resident and was lauded with the program’s sole Teaching Award. Thereafter, Dr. Fishman completed the Consultation-Liaison Psychiatry Fellowship also at the University of Pittsburgh Medical Center. During his training, he also served as Chief Fellow was elected into Alpha Omega Alpha, Honors Medical Society. In the subsequent years, Dr. Fishman practiced as a consultation and liaison psychiatrist, simultaneously serving both academic and community hospitals in the Greater Pittsburgh Area. In his outpatient clinic, he managed and treated patients with complex issues linking the domains of neurology and psychiatry, and specialized in nonepileptic episodes.
Dr. Fishman joined the faculty of Stanford University School of Medicine in 2020 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since his appointment, Dr. Fishman has led medical psychiatry services on the medical/surgical units, intensive care units and in the emergency department at Stanford Hospital to provide psychiatric care for patients with acute diagnoses and provide graduate medical education to psychiatry, internal medicine, palliative care, oncology, and neurology trainees. His work on developing a framework for evidence-based best practice guidelines was recognized with a 2020 DLIN/Fischer finalist award.
Dr. Fishman is the appointed Chief of the Inpatient Proactive Psycho-Oncology Service, a service designed to proactively identify patients with psychopathology or who will require psychiatric intervention during their hospitalization. The service helps prevent development and escalation of psychopathology in the inpatient blood and marrow transplant and other cancer populations. His outpatient work is primarily as a psychiatric oncologist at the Stanford Cancer Center where he provides psychiatric consultation services and collaborates closely with his oncology colleagues to deliver comprehensive cancer care.
His clinical and scholarly interests include the interface of medicine and psychiatry, psycho-oncology, catatonia, neuropsychiatry, collaborative care models, psychotherapy for the medically ill, interdisciplinary and graduate medical education. -
Matthew Fitzgerald, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsMy research encompasses several translational projects. One focus is to modify the routine audiologic test battery such that it places equal weight on hearing acuity and hearing function. This work includes measures of speech in noise, or electrophysiologic responses such as the FFR. I also explore tools to better assess and maximize performance in users of hearing aids and cochlear implants. Finally, I am also investigating the benefits of telemedicine, and new treatments for tinnitus.
-
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.
Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.
Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv. -
Caroline Fleck
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.
More information can be found on her website: https://www.drcarolinefleck.com/ -
Dominik Fleischmann
Professor of Radiology (Cardiovascular Imaging)
Current Research and Scholarly InterestsNon-invasive Cardiovascular Imaging
Image Post-processing
Contrast Medium Dynamics -
Barry Fleisher
Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.
-
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
-
Pamela Flood
Adjunct Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Flood is a Professor at Stanford University who is fellowship trained in Pain Medicine and Obstetric Anesthesiology. She specializes in the treatment of chronic pelvic pain and multiple aspects of women's health including the prevention of chronic pain after childbirth. Research interests include the role of multimodal treatment in chronic pain conditions and prevention of persistent opioid use. Her research has spanned from detailed pharmacodynamic analysis, clinical trials to population health.
-
Lara Foland-Ross
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am an Academic Research Scientist in Neuroscience and Precision Mental Health in the Department of Psychiatry and Behavioral Sciences at Stanford University. I use a variety of imaging modalities to examine the neural and behavioral mechanisms of mood and cognition. The primary aim of my work is to understand how individual brain patterns can be leveraged in treatment planning for depression. My primary projects include the ACE-D study ("Accelerating Cognition-guided signatures to Enhance translation in Depression") in the Stanford Center for Precision Mental Health and Wellness. I deeply value the process of acting on curiosity, learning from challenges, and applying creative solutions to both highlight and address gaps in our understanding of depression and other mental health conditions.
-
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Ann Folkins
Associate Professor of Pathology
Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.
-
Shawna Follis
Instructor, Epidemiology and Population Health
Affiliate, Med/SPRC - DivisionBioShawna Follis, PhD, MS, is an Instructor and K99 Fellow in Epidemiology, researching the risk factors of cardiometabolic diseases. She completed her postdoctoral training at Stanford, as a Propel Postdoctoral Scholar from 2021 to 2023 and a NIH T32 Postdoctoral Fellow from 2020 to 2021. She received her PhD in epidemiology at the University of Arizona and her master’s degree in anthropology from Purdue University.
-
Sai Folmsbee, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.
